Organovo Sues Rival Cellink for Bio-Printing Patent Royalties

July 29, 2021, 4:33 PM

Organovo, a leader in 3D bio-printing, said certain of the Swedish startup Cellink’s bio-printers infringe patents for the technology, whose printed tissues can speed up development of therapeutic drugs.

  • Organovo is seeking cash compensation and court order blocking further unauthorized use of inventions, according to complaint filed Tuesday in federal court in Waco, Texas
  • Organovo owns three of the patents and exclusively licenses another owned by University of Missouri, complaint says
  • Cellink’s Bio X is accused of infringing three patents and its Bio X6 is accused of infringing another
    • Cellink in June filed petition with Patent Trial ...

To read the full article log in. To learn more about a subscription click here.